IP Library Granted Patent US 9,585,681
Granted Patent B2
US 9,585,681 · App. 12/883,087 · Granted Mar 7, 2017

Device and methods for treating paranasal sinus conditions

Inventors: Donald J. Eaton (Los Altos, CA); Thomas R. Tice (Indian Springs, AL); David B. Downie (Cupertino, CA); Patrick A. Arensdorf (Palo Alto, CA); Rodney A. Brenneman (San Juan Capistrano, CA); Danielle L. Biggs (Hoover, AL)
Assignee: Intersect ENT, Inc.
A61B17/24A61K9/0043A61K9/70A61K31/573A61K31/58A61F2/186A61K9/1647
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,585,681
App. No.
12/883,087
Granted
Mar 7, 2017
Kind
B2
Abstract

Described here are paranasal sinus devices for treating paranasal sinus conditions. The devices include a cavity member, ostial member, and nasal portion. One or more of the cavity member, ostial member, and nasal portion may deliver an active agent for sustained release to treat the paranasal sinus condition. Exemplary paranasal sinus conditions are sinus inflammation due to functional endoscopic sinus surgery (FESS) and rhinosinusitis.

Claims (14)

1. A method of delivering a paranasal sinus device comprising:

advancing a bioabsorbable expandable device into a paranasal sinus cavity with a delivery device, the expandable device being sized and shaped to fit within a paranasal sinus cavity and being at least partly conformable to the shape thereof, the expandable device comprising a pronged structure comprising a plurality of filaments that expand radially outwardly, each filament having a proximal end and a distal end, wherein only the proximal ends of each filament join together, and wherein the distal end of each filament is a free distal end; and

withdrawing the delivery device, wherein the expandable device remains in and at least partially conformed to the paranasal sinus cavity after the delivery device has been completely withdrawn.

2. The method of claim 1 wherein the expandable device is configured to biodegrade.

3. The method of claim 2 wherein the expandable device comprises one or more biodegradable polymers.

4. The method of claim 1 wherein the expandable device is configured to release one or more active agents.

5. The method of claim 1 wherein the one or more active agents comprises mometasone furoate.

6. The method of claim 1 wherein the expandable device comprises one or more radiopaque markers.

7. The method of claim 6 further comprising indirectly visualizing the expandable device.

8. The method of claim 1 wherein advancing the expandable device comprises advancing the expandable device under direct visualization.

9. The method of claim 1 wherein the expandable device is self-expanding.

10. The method of claim 1 wherein the expandable device comprises one or more anchoring elements on each filament, wherein the anchoring elements are configured to anchor the expandable device within the paranasal sinus cavity.

11. The method of claim 1 wherein each filament is between about 2 cm and about 5 cm in length.

12. The method of claim 1 wherein the delivery device comprises a handle, a sheath, and a distal portion onto which the expandable device is loaded.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2010
From: EATON, DONALD J.; TICE, THOMAS R.; DOWNIE, DAVID B.; ARENSDORF, PATRICK A.; BRENNEMAN, RODNEY; BIGGS, DANIELLE L.
To: SINEXUS, INC.
Reel/Frame 025408/0204 →
CHANGE OF NAME Recorded Nov 18, 2010
From: SINEXUS, INC.
To: INTERSECT ENT, INC.
Reel/Frame 025408/0375 →
Continuity (3)
Continuation 11398342 · Apr 4, 2006
Provisional Application 60668569 · Apr 4, 2005
Related Publication 20110004192A1 · Jan 6, 2011